Therapeutic window**: When in disease course is intervention most effective?

Pre-Symptomatic Detection and Intervention Timing in Genetic Prion Disease

candidate answer · experiment · 88%

Biomarker-Guided Sequential Therapy Selection in Alzheimer's Disease

discriminating experiment · experiment · 82%

Experiment Proposal (crux): Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-0021 Therapeutic Window in AD — hypothesis chain depends on multiple unproven causal links with no evidence for

candidate answer · experiment_proposal · 78%

s:** - GPR32 knockout in microglia should worsen neuroinflammation if this is the primary mechanism - Dose-response studies showing therapeutic window

candidate answer · experiment · 75%

Blood Biomarker vs Tau PET for Treatment Monitoring

discriminating experiment · experiment · 72%

Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Trials Have Not Succeeded

partial answer for · experiment · 70%

Anti-Tau Immunotherapy Dosing Optimization

partial answer for · experiment · 68%

AD Combination Therapy Trial: Anti-Aβ + Anti-Tau

partial answer for · experiment · 65%

Tau Propagation Causality Test — Does Tau Spread Drive Neurodegeneration or Is It a Bystander?

partial answer for · experiment · 60%

Enteric Nervous System Prion-Like Propagation Blockade

bears on question · hypothesis · 55%

Experiment Proposal (crux): Selective Acid Sphingomyelinase Modulation Therapy — Causal relationship between ASM elevation and disease initiation remains unprove

bears on question · experiment_proposal · 55%

Ganglioside Rebalancing Therapy

bears on question · hypothesis · 55%

TREM2-mediated microglial tau clearance enhancement

bears on question · hypothesis · 50%

Selective Acid Sphingomyelinase Modulation Therapy

bears on question · hypothesis · 50%

Circadian Glymphatic Rescue Therapy (Melatonin-focused)

bears on question · hypothesis · 50%

Experiment Proposal (crux): Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-0021 Therapeutic Window in AD — hypothesis chain depends on multiple unproven causal links with no evidence for

experiment_proposal | candidate_answer

Experiment Proposal (crux): Selective Acid Sphingomyelinase Modulation Therapy — Causal relationship between ASM elevation and disease initiation remains unprove

experiment_proposal | bears_on_question

Ganglioside Rebalancing Therapy

hypothesis | bears_on_question

Selective Acid Sphingomyelinase Modulation Therapy

hypothesis | bears_on_question

Enteric Nervous System Prion-Like Propagation Blockade

hypothesis | bears_on_question

Gamma entrainment therapy to restore hippocampal-cortical synchrony

hypothesis | bears_on_question

Orexin-Microglia Modulation Therapy

hypothesis | bears_on_question

Circadian Glymphatic Rescue Therapy (Melatonin-focused)

hypothesis | bears_on_question

Lysosomal Calcium Channel Modulation Therapy

hypothesis | bears_on_question

R-Loop Resolution Enhancement Therapy

hypothesis | bears_on_question